Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

orchard f prime ucl hematopoietic gene therapy

News and Trends 6 May 2016

Stem cell Biotech gets €26M to Start-off Gene Therapy Development for Children

Orchard Therapeutics has just been launched with a €26M investment led by a major investor. It will be developing gene therapies for a range of blood-related disorders in children. Based in London, Orchard Therapeutics may have just been founded, but it’s based on a long scientific track record. Its founding scientists have been pioneering the area […]

May 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

coverNeovac JeanSibilia MiguelSieler

News and Trends 6 May 2016

Interview with Two Key People of the Fight Against Lupus

I was in Paris this week in the building of the Rare Disease Alliance, an association helping patients affected by a rare disease. The association lend their space to Neovacs, a biotech company from Paris, which was organising a gathering of experts of lupus. Lupus is one of the most common rare disease and affects more than 5 million […]

May 6, 2016 - 1 minutemin - By Joachim Eeckhout

manchester biotechnology biobased propane cyanobacteria

News and Trends 4 May 2016

How the UK is Engineering Bacteria to produce Propane for Greener Fuels

Researchers from the Manchester Institute of Biotechnology are working in engineering a microbe capable of producing propane – an increasingly important fuel. Propane is an emerging fuel, used from heating to transport fuel. Therefore, producing it via synthetic biology has been a major target in the biofuel field to be Greener. This is especially because biobased propane it’s a […]

May 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

Epigenomics cancer colorectal china CFDA beijing biochain diagnostic blood test epiprocolon septin9

News and Trends 4 May 2016

‘First Blood Test for Colorectal Cancer is One of the most Innovative Medical Products’ says Chinese FDA

That’s what the China Food and Drug Administration (CFDA) declared on the blood diagnostic test from Berlin-based Epigenomics‘ proprietary Septin9-Biomarker. Their Septin9 test Epi proColon is filling the need for early detection of colorectal cancer. Data show a huge increase in prevalence in urban China.Just last week we interviewed the CEO of Epigenomics, Thomas Taapken, on the company’s Cancer […]

May 4, 2016 - 3 minutesmins - By Dani Bancroft

glowee crowdfunding wiseed bacteria lighting

News and Trends 4 May 2016

Feel like investing in Bio-Lighting? Here’s your chance

Glowee is bringing its bioluminescent bacteria back to crowdfunding, after raising €41k on Ulule. It is now after €645k to break into the industry – and anyone can invest in them. Glowee is a French start-up that is developing alternative lighting – with bioluminescent bacteria. This bacteria was genetically engineered to express proteins of marine […]

May 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

epistem hepatitis hcv genedrive genotype

News and Trends 3 May 2016

Handheld Genetic Test proves itself for Hep-C with 100% Accuracy

Epistem’s molecular diagnostic (Genedrive) has achieved 100% accuracy in detecting a genotype relevant to Hepatitis – an important proof of concept for this field device. Located in Manchester (UK), Epistem has a market cap of €130,000 and 29 employees. One of its research areas is molecular diagnostics, under which it developed Genedrive. This device can make […]

May 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

ablynx llama antigody nanobody rsv infant

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx is making advances in its Nanobody platform, based on the shorter monoclonal antibodies of llamas. Due to their small size, these Nanobodies can be used in a […]

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

copenhagen biothec genmab symphogen zealand

Best in Biotech 3 May 2016

Here are 12 Biotechs you need to know in Copenhagen – Skål!

With its canals, the Little Mermaid and the oldest amusement park in the world, Copenhagen is at the heart of the world’s obsession with Scandinavia – and it has a biotech scene to match. Pharma and biotech play a strong role in Denmark’s economy. The country is home to some key companies in the field, including […]

May 3, 2016 - 6 minutesmins - By Denise Neves Gameiro

brain tumor medullablastoma oncurious trial tb 403 neuroblastoma cancer

News and Trends 3 May 2016

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

The Belgian biotech startup Oncurious is launching a phase I/IIa trial for an antibody to fight a brain tumor which affects children. Oncurious in Leuven (Belgium) was just launched last April as an emerging oncology company focused orphan drugs for the treatment of pediatric cancers. Its current candidate is preparing for a phase I/IIa trial for the […]

May 3, 2016 - 3 minutesmins - By Dani Bancroft

vatican stem cell research pope biotech biotechnology soon shiong patrick joe biden president

News and Trends 2 May 2016

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

Were you aware of the Vatican’s work in the Biosciences – including Biotech? Well, now it has awarded the Richest Doctor in the world, Patrick Soon-Shiong, some fancy award for his pioneering work against Cancer. AND it held an Adult stem cell therapy research conference with the Pope and US Vice President Joe Biden over the weekend. […]

May 2, 2016 - 4 minutesmins - By Dani Bancroft

galapagos abbvie cystic fibrosis cftr

News and Trends 2 May 2016

Galapagos and AbbVie expand their Cystic Fibrosis collaboration

Galapagos and AbbVie expand their ongoing collaboration in Cystic Fibrosis. With a growth in the portfolio, Galapagos’ milestones increase from €300M to €520M. The most famous collaboration between AbbVie (US) and Galapagos (Belgium) was perhaps their candidate for rheumatoid arthritis – which hit a reef in September, knocking Galapagos’ stock by 39%. But the less […]

May 2, 2016 - 2 minutesmins - By Denise Neves Gameiro

agendia mammaprint breast cancer metastasis risk

News and Trends 2 May 2016

Genetic Diagnostic can cut number of Breast Cancer Patients needing Chemo in Half

Agendia’s shows remarkable clinical results for its genomic assay (MammaPrint) allowed 48% of early-stage breast cancer patients to be spared from chemotherapy. Agendia started out in 2003 as a spin-off from the Netherlands Cancer Institute to commercialize diagnostic tools for cancer. Its first product was MammaPrint, which uses DNA microarray technology to test the activity 70 genes that […]

May 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT